Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 3
2005 4
2006 1
2008 1
2010 4
2012 1
2013 2
2014 3
2015 5
2016 10
2017 15
2018 18
2019 27
2020 35
2021 42
2022 45
2023 57
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

261 results

Results by year

Filters applied: . Clear all
Page 1
Lung Cancer Treatment Advances in 2022.
Abu Rous F, Singhi EK, Sridhar A, Faisal MS, Desai A. Abu Rous F, et al. Among authors: faisal ms. Cancer Invest. 2023 Jan;41(1):12-24. doi: 10.1080/07357907.2022.2119479. Epub 2022 Dec 12. Cancer Invest. 2023. PMID: 36036470
A world, connected.
León AG, Faisal MS. León AG, et al. Among authors: faisal ms. Lancet Haematol. 2023 Jan;10(1):e10. doi: 10.1016/S2352-3026(22)00382-9. Lancet Haematol. 2023. PMID: 36566043 No abstract available.
Microenvironmental control of hematopoietic stem cell fate via CXCL8 and protein kinase C.
Binder V, Li W, Faisal M, Oyman K, Calkins DL, Shaffer J, Teets EM, Sher S, Magnotte A, Belardo A, Deruelle W, Gregory TC, Orwick S, Hagedorn EJ, Perlin JR, Avagyan S, Lichtig A, Barrett F, Ammerman M, Yang S, Zhou Y, Carson WE, Shive HR, Blachly JS, Lapalombella R, Zon LI, Blaser BW. Binder V, et al. Among authors: faisal m. Cell Rep. 2023 May 30;42(5):112528. doi: 10.1016/j.celrep.2023.112528. Epub 2023 May 18. Cell Rep. 2023. PMID: 37209097 Free PMC article.
Evidence-based supportive care in multiple myeloma.
Qureshi A, Tariq MJ, Shah Z, Abu Zar M, Aslam S, Rafae A, Shafqat M, Malik MN, Faisal MS, Anwer F. Qureshi A, et al. Among authors: faisal ms. J Community Hosp Intern Med Perspect. 2020 Aug 2;10(4):313-317. doi: 10.1080/20009666.2020.1771124. J Community Hosp Intern Med Perspect. 2020. PMID: 32850087 Free PMC article. Review.
Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis.
Shahzad M, Nguyen A, Hussain A, Ammad-Ud-Din M, Faisal MS, Tariq E, Ali F, Butt A, Anwar I, Chaudhary SG, Lutfi F, Ahmed N, Singh AK, Hematti P, McGuirk JP, Mushtaq MU. Shahzad M, et al. Among authors: faisal ms. Front Immunol. 2023 Apr 24;14:1152457. doi: 10.3389/fimmu.2023.1152457. eCollection 2023. Front Immunol. 2023. PMID: 37168849 Free PMC article. Review.
Development and Therapeutic Potential of NUAKs Inhibitors.
Faisal M, Kim JH, Yoo KH, Roh EJ, Hong SS, Lee SH. Faisal M, et al. J Med Chem. 2021 Jan 14;64(1):2-25. doi: 10.1021/acs.jmedchem.0c00533. Epub 2020 Dec 24. J Med Chem. 2021. PMID: 33356242 Review.
Gemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia.
Awada H, Abdelmalek M, Cronin T, Baron J, Kashour Z, Azad F, Faisal MS, Faber M, Gravina M, Sung PJ, Green SD, Przespolewski A, Thompson JE, Griffiths EA, Wang ES. Awada H, et al. Among authors: faisal ms. Blood Cancer J. 2023 Sep 4;13(1):131. doi: 10.1038/s41408-023-00910-x. Blood Cancer J. 2023. PMID: 37666807 Free PMC article. No abstract available.
Recent Progress on Circular RNA Research in Acute Myeloid Leukemia.
Jamal M, Song T, Chen B, Faisal M, Hong Z, Xie T, Wu Y, Pan S, Yin Q, Shao L, Zhang Q. Jamal M, et al. Among authors: faisal m. Front Oncol. 2019 Nov 6;9:1108. doi: 10.3389/fonc.2019.01108. eCollection 2019. Front Oncol. 2019. PMID: 31781482 Free PMC article. Review.
261 results